Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease
about
The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis ProjectVariant of TREM2 Associated with the Risk of Alzheimer's DiseaseRepurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's diseaseGenetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and TauopathiesNutrients, Microglia Aging, and Brain AgingFluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsIs neurodegenerative disease a long-latency response to early-life genotoxin exposure?Rodent models of neuroinflammation for Alzheimer's diseaseAmylin at the interface between metabolic and neurodegenerative disordersOxidative stress in Alzheimer's and Parkinson's diseases: insights from the yeast Saccharomyces cerevisiaeBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseArginine deprivation and immune suppression in a mouse model of Alzheimer's diseaseExamining the relationship between head trauma and neurodegenerative disease: A review of epidemiology, pathology and neuroimaging techniquesInvolvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE)--and amyloid beta 1-42-induced signal transduction in glial cellsInhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.A combination cocktail improves spatial attention in a canine model of human aging and Alzheimer's disease.Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways.CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's DiseaseANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.Pathological Hallmarks, Clinical Parallels, and Value for Drug Testing in Alzheimer's Disease of the APP[V717I] London Transgenic Mouse Model.Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.Inflammation and white matter degeneration persist for years after a single traumatic brain injury.Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease.Lipolysaccharide-Induced Neuroinflammation Is Associated with Alzheimer-Like Amyloidogenic Axonal Pathology and Dendritic Degeneration in Rats.The impact of human and mouse differences in NOS2 gene expression on the brain's redox and immune environment.Patterns of Microglial Cell Activation in Alzheimer Disease and Frontotemporal Lobar Degeneration.Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation.Amyloidosis, synucleinopathy, and prion encephalopathy in a neuropathic lysosomal storage disease: the CNS-biomarker potential of peripheral blood.Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation?Sinomenine inhibits microglial activation by Aβ and confers neuroprotection.Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brainsC-Reactive Protein Induces Tau Hyperphosphorylation via GSK3β Signaling Pathway in SH-SY5Y Cells.DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response.Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's diseaseBrain metabolic dysfunction at the core of Alzheimer's disease.T cell immunity to glatiramer acetate ameliorates cognitive deficits induced by chronic cerebral hypoperfusion by modulating the microenvironmentEarly astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography.Microglia in the TBI brain: The good, the bad, and the dysregulated.Nimodipine inhibits IL-1β release stimulated by amyloid β from microglia.
P2860
Q21261508-C5694A72-ACD5-4EE5-A875-E8EF30ED9934Q22250874-3DEABD85-410D-4791-B6D9-B29DC730518BQ26748711-2117019E-C269-4073-80E5-6FB475D21DC4Q26767289-3838BDD0-3BF5-4E5E-A31D-8440AD7D67FFQ26768461-46E54974-F1BB-43AB-84D8-B4E6CBCA2650Q26784569-6D40D050-485D-4218-B3C2-360F8A235949Q26824755-879994BC-7FB7-4BC1-A54D-A7AD0E372985Q26864804-DAB54C67-637D-44BD-A6B6-DE0CB7B0FA97Q27003342-BEA4D723-6437-4B4F-A026-1F04CF657241Q27692067-7393EA87-4747-4038-A876-C622D19A4FACQ28259585-AFCDEDCC-7208-4054-8517-420FC57598FDQ28391826-B5547007-C667-4092-BEDD-584F4A794983Q28395854-D4E3ACFA-2684-449C-AFE1-C806E4172A0FQ28570305-61C9F24A-D177-41C8-ADB1-9519AD02E78FQ30530899-1A6C85AF-9747-4BED-A0EC-29CAAC8FCD9BQ33552777-9959C449-1F81-4187-8ECB-828458C7EF39Q33825472-6BD24FB0-5C09-44ED-A792-D9CA6F6CEE09Q33896118-2769BB2D-5A6A-4631-A395-19ACAFFC0278Q33898577-36396649-84BB-4211-B076-D69DD08CAD97Q34127547-77792D53-94A5-462A-8414-62D1434AB553Q34277859-055F4117-467C-4CB0-886F-DA326EB35DCBQ34299310-3E3EE8FF-F6F3-4F6E-AE20-BDD952D7E05CQ34325388-1BEC2E32-C8AE-4F82-88CA-D188A55AE01CQ34385900-3BAC7750-641E-411A-8763-D2445792242AQ34412996-73CB4945-9858-4B49-B342-06C249B0B789Q34584761-70F77C4E-AC27-4269-9DCA-703F22AAE559Q34681725-FAC7D8BC-81DF-40F5-8788-C1308F6689F2Q34708392-BA3278A5-03E7-4878-9182-1ED970A1F3FFQ35053456-ACF5682D-1FF6-42C0-AA7E-B924F5CBBD52Q35064981-11F4B34E-33D4-4D7B-B9A5-C80509FA62BFQ35240877-9AAFEA4D-AE4F-405B-AA09-E52736D22F8DQ35344466-AD0679E9-948D-4BEA-9CA3-4D6F58E633C6Q35628333-548549CB-3B91-4178-95B1-1BC0CF1D3CDFQ35860733-C932467C-4F09-4C71-8FA5-2CE6A9A0CCDAQ35997824-A25F3E37-FDD4-4F6F-A70A-DAA51D215218Q35997881-66EE4F28-6751-43E6-B1EC-4D0578072ABBQ36099316-DCF2092F-BBB7-4F43-8128-065DAA8D536FQ36265825-CBAEDB65-4865-4527-97C0-03BCE1757803Q36399682-DCEE183D-BC05-4424-AD11-EE1943EFF2EDQ36476748-35463BF0-7DA6-450C-BFCC-F4445631C9F3
P2860
Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Neuroinflammation – An Early E ...... genesis of Alzheimer’s Disease
@ast
Neuroinflammation – An Early E ...... genesis of Alzheimer’s Disease
@en
Neuroinflammation – An Early E ...... genesis of Alzheimer’s Disease
@en-gb
Neuroinflammation – An Early E ...... genesis of Alzheimer’s Disease
@nl
type
label
Neuroinflammation – An Early E ...... genesis of Alzheimer’s Disease
@ast
Neuroinflammation – An Early E ...... genesis of Alzheimer’s Disease
@en
Neuroinflammation – An Early E ...... genesis of Alzheimer’s Disease
@en-gb
Neuroinflammation – An Early E ...... genesis of Alzheimer’s Disease
@nl
altLabel
Neuroinflammation - an early e ...... genesis of Alzheimer's disease
@en
prefLabel
Neuroinflammation – An Early E ...... genesis of Alzheimer’s Disease
@ast
Neuroinflammation – An Early E ...... genesis of Alzheimer’s Disease
@en
Neuroinflammation – An Early E ...... genesis of Alzheimer’s Disease
@en-gb
Neuroinflammation – An Early E ...... genesis of Alzheimer’s Disease
@nl
P2093
P921
P3181
P356
P1476
Neuroinflammation – An Early E ...... genesis of Alzheimer’s Disease
@en
P2093
Annemieke J.M. Rozemuller
Erik van Exel
Jeroen J.M. Hoozemans
Piet Eikelenboom
Rob Veerhuis
Willem A. van Gool
P3181
P356
10.1159/000283480
P407
P577
2010-01-01T00:00:00Z